BML, Inc. 4694.T

Healthcare · Diagnostics & Research · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value
$995.59M
Market Cap
$853.00M
Margin of Safety
14.3%
Intrinsic / Market Ratio
1.17

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.36B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

801.78M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

827.44M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

995.59M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

995.59M USD

from the sum above

Market Cap

853.00M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.17×

the ratio the screener ranks by; Margin of Safety +14.3% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.36B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)961.68M USD
+②Net Cash Today395.87M USD
+③Growth Value0 USD
=Value1.36B USD

EPV of the Operations (NOPAT over WACC)

961.68M USD

Net cash today

+395.87M USD

Growth Value

0 USD

Value

1.36B USD

①EPV (earnings power value)

961.68M USD

②Net Cash Today

395.87M USD

③Growth Value

0 USD

Market value

Market Cap853.00M USD

Today's price times the shares.

Value vs market

Margin of Safety+37.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 801.78M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE333.53M USD
+②Equity at Year 15, Today468.25M USD
=Value801.78M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

333.53M USD

②Equity at Year 15, Today

468.25M USD

Market value

Market Cap853.00M USD

Today's price times the shares.

Value vs market

Margin of Safety-6.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 827.44M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an FCFF at or below zero in the latest three years), so the value is the book value today, 827.44M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap853.00M USD

Today's price times the shares.

Value vs market

Margin of Safety-3.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.73%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.23×Market Risk Premium 6.00%= 5.87%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 24.91M USDPretax Income 75.07M USD= 33.18%

The tax the interest saves.

Interest Expense =EBIT 75.81M USD−Pretax Income 75.07M USD= 745.23K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 745.23K USDTotal Debt 30.16M USD×(1 − Tax Rate for WACC 33.18%)= 1.65%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 30.16M USDMarket Cap + Total Debt 853.00M USD + 30.16M USD= 3.42%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 96.58%×Cost of Equity 5.87%+Debt Weight 3.42%×Cost of Debt 1.65%= 5.73%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 1.15B USD − Total Liabilities 320.14M USD = Book Value Today 827.44M USD

Total Debt 30.16M USD − Cash and Short-Term Investments 426.03M USD = Net Debt Today -395.87M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.8%at most 5%passes37,483,599 / 38,984,139
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets7.1%at least -10.0%passes(129.73M USD − 48.52M USD) ÷ 1.15B USD
Price to bookMarket Cap ÷ Book Value Today1.03×at most 3×passes853.00M USD ÷ 827.44M USD
Operating marginOperating Income ÷ Revenue6.9%above 10.0%does not pass65.27M USD ÷ 941.01M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-1.8%above 10.0%does not pass941.01M USD / 958.01M USD
Net cash(Cash − Total Debt) ÷ Market Cap46.4%above -30%passes(426.03M USD − 30.16M USD) ÷ 853.00M USD
Operating efficiencyOperating Income ÷ Gross Profit21.4%above 25.0%does not pass65.27M USD ÷ 304.91M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

3.57K USD

Enterprise value

84.75B USD

market cap plus net debt

EV / EBITDA

4.21×

Price / book

1.05×

the provider's book

Price / earnings

17.53×

Return on equity

6.2%

the provider's, not the engine's

Profit margin

5.2%

Revenue growth

2.7%

Analyst target, mean

3.80K USD

Analysts

1

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2023202420252026
Income statement

Revenue

1.20B911.93M958.01M941.01M

Gross profit

461.76M301.60M306.83M304.91M

Operating income

179.89M60.59M62.65M65.27M

EBITDA

operating income before depreciation and amortisation

229.06M107.92M117.13M132.93M

Pretax income

181.74M62.95M64.72M75.07M

Net income

117.07M39.88M41.90M48.52M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

117.06M40.24M43.24M44.45M

R&D

————
Balance sheet, year end

Total assets

1.27B1.13B1.22B1.15B

Total liabilities

317.09M270.04M328.52M320.14M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

920.49M831.95M865.74M799.50M

Total debt

31.19M34.80M35.39M30.16M

Cash and equivalents

650.20M489.88M452.02M426.03M

Net PP&E

fixed assets after depreciation

264.15M342.61M418.08M397.84M

Working capital

current assets less current liabilities

657.51M484.70M432.63M380.88M
Cash flow

Operating cash flow

88.24M95.49M105.77M129.73M

Capital expenditure

paid out, so below zero

-48.55M-138.32M-111.45M-63.40M

Depreciation and amortisation

47.02M44.29M51.62M57.12M

Free cash flow

operating cash flow plus capital expenditure

39.69M-42.84M-5.68M66.33M